Patrocinados
Donald Trump's tariff tussle: Duties on Indian pharma would be 'counterproductive’; America may take at least 3 years to match India’s scale, says Pharmexcil
Posted
Despite increased tariffs on Indian imports, the US has temporarily exempted the pharmaceutical sector, recognizing India's critical role in supplying affordable medicines. Pharmexcil emphasizes that tariffs on Indian pharma would harm American consumers, as Indian companies produce low-cost generics. India supplies over 40% of US generic medicines, maintaining high quality standards with numerous FDA-approved facilities.
Buscar
Categorías
- National
- International
- Business
- Technology
- Health
- Educación
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Where can Sanju Samson go next? A closer look at his IPL journey
Sanju Samson, Rajasthan Royals captain, wants to leave after the 2025 season. He has told the...
John Abraham on Trump tariffs and India's oil import policy
John Abraham's film 'Tehran' is ready for release. During promotions, he discussed India-US...
Friedrich Merz halts German military exports to Israel over Gaza issue; urges aid access
Germany's Chancellor Friedrich Merz announced a halt to military equipment exports to Israel that...
Lekhraj Bhatta endorses KP Oli as an essential leader for Nepal’s politics
KATHMANDU: Nepal Communist Party (UML) Secretary Lekhraj Bhatta has stated that party Chairperson...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Spanish
